Direct-fed Microbials Market

The direct-fed microbials (DFM) market is projected to grow at a CAGR of 6.96% to reach USD 1,399.6 Million by 2022. The market is driven by factors such as increase in awareness about feed quality and safety, rising demand for manufactured animal feed, growth in demand for animal protein, changes in farming practices and technology, and replacing antibiotic growth promoters (AGPs) with direct-fed microbials. The continuous rise in the population has also resulted in an increase in the demand for food and the necessity for direct-fed microbials, to increase meat and milk production in a sustainable manner.

The consumption of direct-fed microbials is increasing significantly with various government regulations being adopted to improve animal health. The ban on the use of antibiotics as growth promoters in the European Union has created massive demand for direct-fed microbials. On the basis of type, the lactic acid bacteria segment is expected to be the fastest-growing, as these direct-fed microbials are highly effective.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91112718

Significant growth expected in the lactic acid bacteria segment

Lactic acid bacteria are gaining high popularity in the direct-fed microbials (DFM) market across the world, the demand for lactic acid bacteria used in feed for animal health and nutrition have been contributing to the growth in the market. Lactic acid bacteria are more convenient to use, owing to their ease in application. They are the most widely used direct-fed microbials and hence, the lactic acid bacteria segment is projected to be the fastest-growing for the next six years.

Significant growth in demand for direct-fed microbials in animal feed observed in the North American region

Due to recent outbreaks of diseases such as avian influenza or avian flu, and foot & mouth disease, the meat market in North America, especially in the U.S., has become cautious about food safety and quality. The U.S. government took initiatives such as the complete ban, in 2009, on the use of feed antibiotics as growth promoters, and campaigns for increasing awareness about product efficiency and its proper usage. With the ban on the use of feed antibiotics as growth promoters, the direct-fed microbials (DFM) market in North America has grown.

This report includes a study of marketing and development strategies, along with the product portfolio of leading companies. It includes the profiles of leading companies such as Archer Daniels Midland Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), Koninklijke DSM N. V. (Netherlands), Novozymes (Denmark), Chr. Hansen A/S (Denmark), Kemin Industries (U.S.), BIOMIN Holding GmbH (Austria), Lallemand Inc. (Canada), Novus International, Inc. (U.S.), and Bio-vet (U.S.).

Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=91112718

Target Audience:

• Direct-fed microbial manufacturers
• Feed manufacturers
• Animal pharmaceutical companies
• Direct-fed microbial raw material suppliers
• Direct-fed microbial product exporters & importers
• Educational institutions
• Regulatory authorities
• Consulting firms